We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

vrijdag 1 december 2017

Gene Therapy - Table of Contents alert Volume 24 Issue 11

If you are unable to see the message below, click here to view.
Gene Therapy

Need High Titer AAV Fast?
  • High Titer > 10e13-14 GC/ml
  • Delivered in 2 weeks
Learn more about Vigene's AAV services

Volume 24, Issue 11 (November 2017)

In this issue
Original Articles
Short Communications

Also new

Nature Outlook: Blood

Blood is the epicentre of much biomedical research, from fighting disease to creating artificial substitutes for this vital fluid. This Outlook discusses topics such as a gene-editing treatment for sickle-cell disease and keeping the blood supply safe from pathogens. 

Get free access 

Produced with support from: Grifols 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles


An efficient, non-viral dendritic vector for gene delivery in tissue engineering

D P Walsh, A Heise, F J O’Brien and S-A Cryan

Gene Ther 2017 24: 681-691; advance online publication, September 14, 2017; 10.1038/gt.2017.58

Abstract | Full Text

Delivery of human erythropoietin gene with an adeno-associated virus vector through parotid glands to treat renal anaemia in a swine model

C Ma, Z Fan, Z Gao, S Wang and Z Shan

Gene Ther 2017 24: 692-698; advance online publication, July 28, 2017; 10.1038/gt.2017.70

Abstract | Full Text

Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo

L Wang, I Vuletic, D Deng, W Crielaard, Z Xie, K Zhou, J Zhang, H Sun, Q Ren and C Guo

Gene Ther 2017 24: 699-705; advance online publication, August 14, 2017; 10.1038/gt.2017.74

Abstract | Full Text

Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis

A Tomaru, T Kobayashi, J A Hinneh, P Baffour Tonto, C N D'Alessandro-Gabazza, H Fujimoto, K Fujiwara, Y Takahashi, M Ohnishi, T Yasuma, K Nishihama, M Yoshino, K Takao, M Toda, T Totoki, Y Takei, K Yoshikawa, O Taguchi and E C Gabazza

Gene Ther 2017 24: 706-716; advance online publication, August 18, 2017; 10.1038/gt.2017.80

Abstract | Full Text

Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis

I Fishbein, D T Guerrero, I S Alferiev, J B Foster, N G Minutolo, M Chorny, A M Monteys, K H Driesbaugh, C Nagaswami and R J Levy

Gene Ther 2017 24: 717-726; advance online publication, August 23, 2017; 10.1038/gt.2017.82

Abstract | Full Text

A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and vitamin D binding protein siRNA

M Choi, J Gu, M Lee and T Rhim

Gene Ther 2017 24: 727-734; advance online publication, August 28, 2017; 10.1038/gt.2017.83

Abstract | Full Text

Short Communications


Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina

B Ameline, K-T Tshilenge, M Weber, M Biget, L Libeau, R Caplette, A Mendes-Madeira, N Provost, C Guihal, S Picaud, P Moullier, V Pichard, T Cronin and C Isiegas

Gene Ther 2017 24: 735-741; advance online publication, September 7, 2017; 10.1038/gt.2017.63

Abstract | Full Text

Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII gene

J M Staber, M J Pollpeter, C-G Anderson, M Burrascano, A L Cooney, P L Sinn, D T Rutkowski, W C Raschke and P B McCray

Gene Ther 2017 24: 742-748; advance online publication, September 14, 2017; 10.1038/gt.2017.67

Abstract | Full Text

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model

M Täger, S Horn, E Latuske, P Ehm, M Schaks, M Nalaskowski, B Fehse, W Fiedler, C Stocking, J Wellbrock and M Jücker

Gene Ther 2017 24: 749-753; advance online publication, November 16, 2017; 10.1038/gt.2017.88

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature